While the studies presented here indicate ACE inhibition may improve T2DM-induced cardiovascular autonomic dysfunction, further clinical studies with larger sample sizes are necessary to definitively assess the therapeutic potential of ACE inhibitors. Here, ACE is linked to type 2 diabetes mellitus.